S100A4 Is a Targetable Regulator of Immune Suppression in Glioblastoma
Thomas Wong, Jia-Shiun Leu, Maryam Faisal…·Kyuson Yun
This study identifies S100A4 as a targetable regulator of immune suppression in glioblastoma, showing its inhibition enhances immunotherapy response and survival.